Status Approved
First Submitted Date
2012/12/28
Registered Date
2013/01/10
Last Updated Date
2013/11/21
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0000628 |
---|---|
Unique Protocol ID | KI1210 |
Public/Brief Title | Acupuncture for lateral epicondylitis (tennis elbow): a Randomized, Practitioner-Assessor blinded, Controlled Pilot Clinical Trial |
Scientific Title | Acupuncture for lateral epicondylitis (tennis elbow): a Randomized, Practitioner-Assessor blinded, Controlled Pilot Clinical Trial |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | djomc-100-1 |
Approval Date | 2013-01-14 |
Institutional Review Board Name | Institutional Review Board of Oriental Hospital of Daejeon University |
Institutional Review Board Address | |
Institutional Review Board Telephone | |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Kwon Eui Hong |
Title | Doctor |
Telephone | +82-42-223-2951 |
Affiliation | Daejeon Korean Medicine Hospital of Daejeon University |
Address | |
Contact Person for Public Queries | |
Name | Kyungmin Shin |
Title | Doctor |
Telephone | +82-42-223-4051 |
Affiliation | Korea Institute of Oriental Medicine |
Address | |
Contact Person for Updating Information | |
Name | Kyungmin Shin |
Title | Doctor |
Telephone | +82-42-223-4051 |
Affiliation | Korea Institute of Oriental Medicine |
Address |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Recruiting | |
Date of First Enrollment | 2013-02-11 Anticipated | |
Target Number of Participant | 45 | |
Primary Completion Date | 2013-11-29 , Anticipated | |
Study Completion Date | 2013-11-29 , Anticipated | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Daejeon Korean Medicine Hospital of Daejeon University | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2013-02-11 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Korea Institute of Oriental Medicine |
Organization Type | Research Institute |
Project ID | K12010 |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Korea Institute of Oriental Medicine |
Organization Type | Research Institute |
7. Study Summary
Lay Summary | This is a pilot study comparing the efficacy of of ipsilateral acupuncture, contralateral acupuncture and sham acupuncture on lateral epicondylitis, to assess the efficacy of contralateral acupuncture. This study is a parallel design pilot study with random assignment and practitioner-examiner blind tests. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Treatment |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Single |
Blinded Subject | Investigator, Outcome Accessor |
Allocation | RCT |
Intervention Type | Medical Device |
Intervention Description | Forty-five subjects with lateral epicondylitis will be randomized into three groups: the ipsilateral acupuncture group, contralateral acupuncture group and the sham acupuncture group. All 3 groups receive 10 acupuncture treatments over 4 weeks. |
Number of Arms | 3 |
Arm 1 |
Arm Label ipsilateral acupuncture group |
Target Number of Participant 15 |
|
Arm Type Experimental |
|
Arm Description Acupuncture treatment will be given 10 times in total for 4 weeks. Ipsilateral acupuncture group will receive acupuncture on LI4, TE5, LI10, LI11, LU5, LI12 and two Ashi points and the needles will be maintained for 20 minutes. |
|
Arm 2 |
Arm Label Contralateral acupuncture group |
Target Number of Participant 15 |
|
Arm Type Active comparator |
|
Arm Description The contralateral acupuncture groupreceived the same frequency, duration, and total number of treatments as the ipsilateral acupuncture group . Needles are inserted at the same acupoints of the unaffected side by using the same manual technique and acupuncture duration. |
|
Arm 3 |
Arm Label sham aupuncture group |
Target Number of Participant 15 |
|
Arm Type Sham comparator |
|
Arm Description For the control group, the acupoints used are unrelated to the treatment of tennis elbow(BL13, Bl14, Bl15 and Bl16) and non-invasive techniques will be used for 20 min. |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (M00-M99)Diseases of the musculoskeletal system and connective tissue (M77.1)Lateral epicondylitis |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 19Year~65Year |
|
Description 1. Individuals between the ages of 19 and 65 years with tennis elbow on one arm and pain persisting for at least 4 weeks. 2. Individuals with tenderness limited to the elbow joint and surrounding area. 3. Individuals reporting pain under resisted extension of the middle finger and wrist. 4. Individuals with an average pain of 4 or more (0-10) on the numeric rating scale (NRS) in the week prior to the screening visit. 5. Individuals who volunteered to participate in the study and who signed a consent form. |
|
Exclusion Criteria |
1. Individuals whose radiological examinations show abnormalities such as calcification, arthritis, and inflammatory arthropathy of the tennis elbow. 2. Individuals with a history of trauma, ligament damage, fracture, tumor, or surgery of the elbow joint. 3. Individuals who have been diagnosed with or treated for cervical radiculopathy or herniation of intervertebral disc. 4. Individuals who have received injections for tennis elbow during the last 6 months 5. Individuals who have received treatments such as non-steroidal anti-inflammatory drugs (NSAIDs), acupuncture, physiotherapy for tennis elbow during the last 2 weeks 6. Individuals who as per the clinical research coordinator were considered as unsuitable for participation, such as those with mental disorders, who are pregnant, or with other acute or chronic disorders. |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | /Safety/Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | 100mm Pain VAS(Visual analogue Scale) |
|
Timepoint | after the completion of the treatment |
|
Secondary Outcome(s) 1 | ||
Outcome | 100mm Pain VAS(Visual analogue Scale) |
|
Timepoint | 8 weeks and 12 weeks after the random assignment |
|
Secondary Outcome(s) 2 | ||
Outcome | Patient-rated tennis elbow evaluation (PRTEE) |
|
Timepoint | after the completion of the treatment, 8 weeks and 12 weeks after the random assignment |
|
Secondary Outcome(s) 3 | ||
Outcome | Pain-free/maximum grip strength (Dynamometer) |
|
Timepoint | after the completion of the treatment, 8 weeks and 12 weeks after the random assignment |
|
Secondary Outcome(s) 4 | ||
Outcome | Patient global assessment |
|
Timepoint | after the completion of the treatment, 8 weeks and 12 weeks after the random assignment |
|
Secondary Outcome(s) 5 | ||
Outcome | EuroQol-5 Dimension (EQ-5D) |
|
Timepoint | after the completion of the treatment, 8 weeks and 12 weeks after the random assignment |
|
Secondary Outcome(s) 6 | ||
Outcome | Southampton Needle Sensation Questionnaire |
|
Timepoint | after the completion of the treatment, 8 weeks and 12 weeks after the random assignment |
|
Secondary Outcome(s) 7 | ||
Outcome | Pressure pain threshold (Pressure Algometer) |
|
Timepoint | after the completion of the treatment, 8 weeks and 12 weeks after the random assignment |
|
Secondary Outcome(s) 8 | ||
Outcome | Clinically relevant improvement |
|
Timepoint | after the completion of the treatment, 8 weeks and 12 weeks after the random assignment |
11. Study Results and Publication
Result Registered |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | Not provided at time of Registration |
---|
TOP
BOTTOM
화면 최하단으로 이동